companydata.dkcompanydata.dk

SALFARM DANMARK A/S: Financial statements 2022

CVR: 67456211

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

SALFARM DANMARK A/S (CVR 67456211) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 44,005,861 and a net result of DKK 24,973,896 compared with DKK 24,987,497 the year before. That is a decrease of 1.6% compared with the year before. Equity in the 2022 report amounted to DKK 34,173,900. The solvency ratio was 65.1%. The company had 16 employees in the financial year.

Gross Profit
DKK 44,005,861
Profit/Loss
DKK 24,973,896
Equity
DKK 34,173,900
Total Assets
DKK 52,524,769
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-44M25M34.2M16
2021-44.7M25M34.2M15
2020-36.6M21.4M34.2M12
2019-26.9M11.3M20.9M12
2018-23.8M7.9M16.5M11

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SALFARM DANMARK A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

SALFARM DANMARK A/S appoints new auditorNov 22, 2022

As of November 22, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of SALFARM DANMARK A/S.

Auditor steps down at SALFARM DANMARK A/SNov 22, 2022

As of November 22, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of SALFARM DANMARK A/S.

SALFARM DANMARK A/S: The 2021 annual report is outMar 6, 2022

SALFARM DANMARK A/S has published its annual report for 2021. Gross profit came to DKK 44,716,820, and the net result was DKK 24,987,497.

About SALFARM DANMARK A/S

SALFARM DANMARK A/S is a Danish company of the type Aktieselskab based in Kolding, founded in 1981. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Peter Wendorff Olsen. The board consists of Michael Degn-Mortensen (chair), Peter Wendorff Olsen and Simon Damkjær Wille. The company is owned by SALPHARM HOLDING ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 68,137,143 and a net result of DKK 37,103,807 compared with DKK 31,245,958 the year before. Equity in the 2025 report amounted to DKK 41,267,696.

Source: annual report 2025, Danish Business Authority